Contract 36F79723D0171
Partner Therapeutics, Inc. · Department Of Veterans Affairs · September 3, 2025
Partner Therapeutics, Inc. was awarded a federal contract by Department Of Veterans Affairs on September 3, 2025 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 3, 2025. If all options are exercised, the contract could reach $4.41 million.
Contract details
- PIID
- 36F79723D0171
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 3, 2025
- Latest action
- December 3, 2025
Description
2026 PUBLIC LAW PRICING UPDATES
Modification timeline
-
December 3, 2025Mod P00005 · Supplemental Agreement For Work Within Scope$0
-
September 3, 2025Mod P00004 · Supplemental Agreement For Work Within ScopeLIFECYCLE UPDATE$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79723D0171?
Contract 36F79723D0171 is a federal contract awarded to Partner Therapeutics, Inc. by Department Of Veterans Affairs on September 3, 2025 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 36F79723D0171?
Partner Therapeutics, Inc. won contract 36F79723D0171 from Department Of Veterans Affairs.
How much is contract 36F79723D0171 worth?
Contract 36F79723D0171 has obligated $0 to date but carries a potential ceiling of $4.41 million if fully funded and all options are exercised.